Jie-Ming Qu is Chief Physician of Pulmonary Diseases and Critical Care Medicine, and Director of the Institute of Respiratory Diseases, at the Medical school of Shanghai Jiao-Tong University, in China. He is also President of the Chinese Thoracic Society (CTS) and Head of the CTS pulmonary infection group, among other key positions. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. See, for example: Bin Cao is Vice President of the China-Japan Friendship Hospital and Deputy Dean of the Respiratory Medicine Research Institute at the Chinese Academy of Medical Sciences. He holds several other senior positions, including as Professor at Capital Medical University, and Tsinghua University-Peking University Joint Center for Life Sciences, Beijing. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. Rong-Chang Chen is Chief Physician of Pulmonary Diseases and Critical Care Medicine, Director of the Shenzhen Institute of Respiratory Disease, and Deputy Director of the National Clinical Research Center of Respiratory Disease, China. In addition he is former President of the Chinese Thoracic Society (CTS) and former director of Guangzhou Institute of Respiratory Health. He has published widely, including on the initial outbreak of the 2019 novel coronavirus.

Select Guide Rating

• 1. Respiratory viruses and COVID-192. Pathogenesis of COVID-193. Case definitions and diagnosis of COVID-194. Treatment of COVID-195. Prevention and disease control of COVID-196. Prospects of the management and research of respiratory virus infection

Jie-Ming Qu is Chief Physician of Pulmonary Diseases and Critical Care Medicine, and Director of the Institute of Respiratory Diseases, at the Medical school of Shanghai Jiao-Tong University, in China. He is also President of the Chinese Thoracic Society (CTS) and Head of the CTS pulmonary infection group, among other key positions. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. See, for example: Bin Cao is Vice President of the China-Japan Friendship Hospital and Deputy Dean of the Respiratory Medicine Research Institute at the Chinese Academy of Medical Sciences. He holds several other senior positions, including as Professor at Capital Medical University, and Tsinghua University-Peking University Joint Center for Life Sciences, Beijing. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. Rong-Chang Chen is Chief Physician of Pulmonary Diseases and Critical Care Medicine, Director of the Shenzhen Institute of Respiratory Disease, and Deputy Director of the National Clinical Research Center of Respiratory Disease, China. In addition he is former President of the Chinese Thoracic Society (CTS) and former director of Guangzhou Institute of Respiratory Health. He has published widely, including on the initial outbreak of the 2019 novel coronavirus.

Select Guide Rating

• 1. Respiratory viruses and COVID-192. Pathogenesis of COVID-193. Case definitions and diagnosis of COVID-194. Treatment of COVID-195. Prevention and disease control of COVID-196. Prospects of the management and research of respiratory virus infection

Jie-Ming Qu is Chief Physician of Pulmonary Diseases and Critical Care Medicine, and Director of the Institute of Respiratory Diseases, at the Medical school of Shanghai Jiao-Tong University, in China. He is also President of the Chinese Thoracic Society (CTS) and Head of the CTS pulmonary infection group, among other key positions. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. See, for example: Bin Cao is Vice President of the China-Japan Friendship Hospital and Deputy Dean of the Respiratory Medicine Research Institute at the Chinese Academy of Medical Sciences. He holds several other senior positions, including as Professor at Capital Medical University, and Tsinghua University-Peking University Joint Center for Life Sciences, Beijing. He has published widely, including on the initial outbreak of the 2019 novel coronavirus. Rong-Chang Chen is Chief Physician of Pulmonary Diseases and Critical Care Medicine, Director of the Shenzhen Institute of Respiratory Disease, and Deputy Director of the National Clinical Research Center of Respiratory Disease, China. In addition he is former President of the Chinese Thoracic Society (CTS) and former director of Guangzhou Institute of Respiratory Health. He has published widely, including on the initial outbreak of the 2019 novel coronavirus.

Select Guide Rating

• 1. Respiratory viruses and COVID-192. Pathogenesis of COVID-193. Case definitions and diagnosis of COVID-194. Treatment of COVID-195. Prevention and disease control of COVID-196. Prospects of the management and research of respiratory virus infection